Michal Mielcarek

Michal Mielcarek

Imperial College London - London / United Kingdom
Others
AD Scientific Index ID: 1272410
person_outline Michal Mielcarek's MOST POPULAR ARTICLES
1-) Gene therapy advances: a meta-analysis of AAV usage in clinical settingsHKE Au, M Isalan, M MielcarekFrontiers in medicine 8, 809118, 20221862022
2-) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegenerationM Mielcarek, C Landles, A Weiss, A Bradaia, T Seredenina, L Inuabasi, ...PLoS biology 11 (11), e1001717, 20131852013
3-) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington\\\\\\\'s diseaseM Mielcarek, CL Benn, SA Franklin, DL Smith, B Woodman, PA Marks, ...PloS one 6 (11), e27746, 20111732011
4-) Skeletal muscle pathology in Huntington\'s diseaseD Zielonka, I Piotrowska, JT Marcinkowski, M MielcarekFrontiers in physiology 5, 380, 20141352014
5-) HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievementsM Mielcarek, D Zielonka, A Carnemolla, JT Marcinkowski, F GuidezFrontiers in cellular neuroscience 9, 42, 20151122015